Evidence map›Paper›PMID 38601915›Full record

ArticleBrain communications2024

Association of abnormal explicit sense of agency with cerebellar impairment in myoclonus-dystonia.

Clément Tarrano, Cécile Galléa, Cécile Delorme, Eavan M McGovern, Cyril Atkinson-Clement, Isaac Jarratt Barnham, Vanessa Brochard, Stéphane Thobois, Christine Tranchant, David Grabli and 13 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Distinct Brain Drivers and Shared Cerebello-Cortical Input in ADCY5 and SGCE Hyperkinetic Movements.Movement disorders : official journal of the Movement Disorder Society · 2026
    Article
  2. Review
  3. Brain network pathophysiology in dystonia.Dystonia (Lausanne, Switzerland) · 2025
    Article
  4. Sex-specific alterations of Purkinje cell firing inDystonia (Lausanne, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 3 countries.

Clément TarranoCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.ORCID https://orcid.org/0000-0001-5627-2126
Cécile GalléaCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Cécile DelormeCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Eavan M McGovernDepartment of Neurology, Beaumont Hospital, Dublin 9, D09 VY21, Ireland.
Cyril Atkinson-ClementCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.ORCID https://orcid.org/0000-0001-9499-3485
Isaac Jarratt BarnhamDepartment of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, UK.ORCID https://orcid.org/0000-0002-3875-0881
Vanessa BrochardAssistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Neurology, Clinical Investigation Center for Neurosciences, Paris 75013, France.
Stéphane ThoboisDepartment of Neurology, Hospices Civils de Lyon, Lyon 69000, France.
Christine TranchantDépartement de Neurologie, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg 67098, France.
David GrabliCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Bertrand DegosDepartment of Neurology, Assistance Publique-Hôpitaux de Paris, Avicenne Hospital, Sorbonne Paris Nord, Bobigny 93000, France.
Jean Christophe CorvolCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Jean-Michel PedespanDepartment of Neuropediatry, Universitary Hospital of Pellegrin, Bordeaux 33076, France.
Pierre KrystkowiakDepartment of Neurology, Abu Dhabi Stem Cells Centre, Abu Dhabi, United Arab Emirates.
Jean-Luc HouetoDepartment of Neurology CHU Limoges, Inserm U1094, IRD U270, Univ. Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges 87000, France.ORCID https://orcid.org/0000-0002-6029-8289
Adrian DegardinDepartment of Neurology, Tourcoing Hospital, Tourcoing 59599, France.
Luc DefebvreDepartment of Neurology, University of Lille, Lille 59000, France.
Romain ValabrègueCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Benoit BerangerCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Emmanuelle ApartisCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Marie VidailhetCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Emmanuel RozeCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.
Yulia WorbeCNRS UMR 7225, Sorbonne Université, Paris Brain Institute-Institut du Cerveau et de la Moelle épinière, Inserm U1127, Paris 75013, France.ORCID https://orcid.org/0000-0001-5903-9370
Centre National de la Recherche Scientifique · FRCentre Hospitalier de Tourcoing · FRHôpital Pellegrin · FRHospices Civils de Lyon · FRInserm · FRRoyal College of Surgeons in Ireland · IESorbonne Université · FRUniversité de Lille · FRUniversité Sorbonne Paris Nord · FRUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-motor aspects in dystonia are now well recognized. The sense of agency, which refers to the experience of controlling one's own actions, has been scarcely studied in dystonia, even though its disturbances can contribute to movement disorders. Among various brain structures, the cerebral cortex, the cerebellum, and the basal ganglia are involved in shaping the sense of agency. In myoclonus dystonia, resulting from a dysfunction of the motor network, an altered sense of agency may contribute to the clinical phenotype of the condition. In this study, we compared the explicit and implicit sense of agency in patients with myoclonus dystonia caused by a pathogenic variant of

Indexed as

cerebellummetacognitionMRImyoclonus dystoniasense of agency

Identifiers

PMID38601915
PMCPMC11004927
OpenAlexW4393220468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.